Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2007
10/25/2007CA2648932A1 Brimonidine and timolol compositions
10/25/2007CA2648659A1 Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
10/25/2007CA2648537A1 Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil)
10/25/2007CA2647705A1 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives
10/25/2007CA2646400A1 Glucagon-like peptide 1(glp-1) pharmaceutical formulations
10/25/2007CA2646289A1 Wound dressings with anti-microbial and zinc-containing agents
10/25/2007CA2643807A1 Homeopathic composition and kit therefore
10/25/2007CA2643728A1 Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
10/25/2007CA2643662A1 Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
10/25/2007CA2643295A1 Modified release formulations and methods of treating inflammatory bowel disease
10/24/2007EP1847548A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
10/24/2007EP1847315A1 Method for coating particle with lipid film
10/24/2007EP1847271A2 Water-absorbent polymers and their use as a medicament
10/24/2007EP1847268A1 Multiple unit oral sustained release preparation and process for production of the same
10/24/2007EP1847264A1 Patch
10/24/2007EP1847261A1 Assembly of devices used for the production of microcapsules for the controlled release of peptides
10/24/2007EP1847260A2 Solid dispersion preparation
10/24/2007EP1847259A1 Compositions comprising thieno[2,3-c]pyridine derivatives as active agents with poloxamers as lubricants
10/24/2007EP1847258A1 Partial glycerides as lubricants in pharmaceutical compositions comprising thieno[3,2-c]pyridine derivatives
10/24/2007EP1847257A2 Solid preparation comprising enteric solid dispersion
10/24/2007EP1847256A1 Antibacterial compositions for the treatment of infections of the upper and lower airways
10/24/2007EP1847255A2 Sustained release drug delivery devices with coated drug cores
10/24/2007EP1847253A1 Water-soluble polymers and their application in cosmetic and pharmaceutical preparations
10/24/2007EP1846457A1 Biodegradable hydrogels
10/24/2007EP1846382A2 Controlled release compositions comprising an antipsychotic agent
10/24/2007EP1846153A2 Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
10/24/2007EP1846152A1 Stabilized crystallized catanionic nanodiscs, method for preparing same and uses thereof
10/24/2007EP1846145A1 Mixing apparatus
10/24/2007EP1846037A1 Methods of treating various conditions by administration of sustained release l-arginine
10/24/2007EP1846014A2 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally senstive transmembrane peptide
10/24/2007EP1846012A1 Stabilised plant extract and its therapeutic use
10/24/2007EP1846009A2 Improved device for application of medicaments, manufacturing method therefor, and method of treatment
10/24/2007EP1846005A2 Kits and improved compositions for treating lower urinary tract
10/24/2007EP1846000A1 Pharmaceutical compositions containing bisphosphonate for improving oral absorption
10/24/2007EP1845996A1 Compositions and methods relating to novel compounds and targets thereof
10/24/2007EP1845983A1 Ophthalmic compositions and methods of using the same
10/24/2007EP1845982A2 Stable oral benzimidazole compositions prepared by non-aqueous layering process
10/24/2007EP1845977A1 Oral dosage form comprising rosiglitazone
10/24/2007EP1845968A2 Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
10/24/2007EP1845960A1 A tooth cleaning kit comprising at least one set of chewing gum pieces
10/24/2007EP1845959A2 Medicament that is intended for oral administration, comprising a cyclooxygenase-2 inhibitor, and preparation method thereof
10/24/2007EP1845958A2 Anti-misuse microparticulate oral drug form
10/24/2007EP1845957A1 Method for producing a drug extract that contains hydroxystilbene
10/24/2007EP1845956A1 Break-resistant delayed-release forms of administration
10/24/2007EP1845955A1 Method for the production of a tamper-proof form of administration
10/24/2007EP1845954A2 Orally disintegrating composition of olanzapine or donepezil
10/24/2007EP1845953A1 Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
10/24/2007EP1845952A2 Stable tablet formulation of tetrahydrobiopterin
10/24/2007EP1845951A2 Embolization using poly-4-hydroxybutyrate particles
10/24/2007EP1845950A2 Fast wet-massing method for the preparation of calcium-containing compositions
10/24/2007EP1845949A1 Melt granulation of a composition containing a calcium-containing compound
10/24/2007EP1845948A2 Colonic delivery of active agents
10/24/2007EP1845947A2 Fast-disintegrating microporous binder and process for making it
10/24/2007EP1845946A2 Pharmaceutical compositions useful in the transmucosal administration of drugs
10/24/2007EP1845945A1 Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
10/24/2007EP1845944A2 Pharmaceutical compositions
10/24/2007EP1845943A2 Nano- and mesosized particles comprising an inorganic core, process and applications thereof
10/24/2007EP1845942A1 Gnrh analogue formulations
10/24/2007EP1845941A1 Syrup composition comprising dexibupropen as an active ingredient and method for the preparation thereof
10/24/2007EP1845940A1 Hair relaxer
10/24/2007EP1845939A1 Drug delivery materials made by sol/gel technology
10/24/2007EP1845938A1 Methods and related compositions for reduction of fat and skin tightening
10/24/2007EP1845937A1 Pharmaceutical composition for improving palatability of drugs and process for preparation thereof
10/24/2007EP1845932A1 Stable tooth whitening gum with reactive ingredients
10/24/2007EP1845925A2 Method for delivering interferon-
10/24/2007EP1845777A2 Starch derivatives and other derivatives, production processes therefor, and wound healing applications therefor
10/24/2007EP1755630B1 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use
10/24/2007EP1587517B1 Anti-protozoal compositions comprising diclazuril
10/24/2007EP1506041B1 Ibandronic acid for the treatment and prevention of osteoporosis
10/24/2007EP1505980B1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
10/24/2007EP1478343A4 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
10/24/2007EP1471899B1 Use of ambroxol in the treatment of chronic pain
10/24/2007EP1383556B1 INJECTION DEVICE FOR ADMINISTERING mRNA
10/24/2007EP1312366B1 Gelling aqueous pharmaceutical compositions
10/24/2007EP1212020B1 Disposable thermal body wrap
10/24/2007EP1207860B1 Controlled release pellet formulation
10/24/2007EP1156797B1 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
10/24/2007EP1156783B1 Encapsulation of bioactive complexes in liposomes
10/24/2007CN200963353Y 瘢痕膏药贴 Scar plaster paste
10/24/2007CN200963352Y Plastic film rubberized paste
10/24/2007CN101061220A Stabilisation of granules comprising active compounds
10/24/2007CN101060915A Process and device for producing finely divided liquid-liquid formulations, and the uses of these liquid-liquid formulations
10/24/2007CN101060888A Acidic solid oral compositions without erosive potential in saliva and method for determining erosive potential in saliva
10/24/2007CN101060887A Oral care compositions
10/24/2007CN101060886A Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
10/24/2007CN101060862A Composition for oral or rectal administration
10/24/2007CN101060846A Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
10/24/2007CN101060835A Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration
10/24/2007CN101060834A Small particle copper pyrithione
10/24/2007CN101060833A Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom
10/24/2007CN101060832A Nonaqueous liquid parenteral aceclofenac formulation
10/24/2007CN101060831A Conveniently implantable sustained release drug compositions
10/24/2007CN101060830A Combination of a NMDA receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
10/24/2007CN101058680A Pigment
10/24/2007CN101058610A Codonopsisbulleyana polysaccharide sulfate and use thereof
10/24/2007CN101058608A Human anti-Abeta(1-32) amyloid antibody, purifying method and use thereof
10/24/2007CN101058576A Rhizoma corydalis decumbentis extract, preparation method thereof, medicament composition containing the rhizoma corydalis decumbentis and application thereof
10/24/2007CN101058573A 2-hydrazone substituted triazine compound, preparation method thereof, and medicinal composition and use using same as active component
10/24/2007CN101058566A Novel medicinal salt for cinepazide and preparation method thereof
10/24/2007CN101058561A Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof
1 ... 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 ... 2991